Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

IFEDAPO OLUBUKOLA SOTUBO

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1063000909
CMS profile
9535540
Location
WEBSTER, TX

General Payments · PY2021–2025

$630.51

  • Reported across 32 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$329.40

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $329.40 15

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
ViiV Healthcare Company $274.70 12
Gilead Sciences, Inc. $37.93 2
Acerta Pharma LLC $16.77 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $60.22 4
PY2022 $222.86 12
PY2024 $18.03 1
PY2025 $329.40 15

Payment records · PY2025 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2025 202120222024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $16.77 10/30/2025 Food and Beverage Undisputed 06/30/2026 1206844380 CMS
Gilead Sciences, Inc. $15.31 03/19/2025 Food and Beverage Undisputed 06/30/2026 1234570314 CMS
Gilead Sciences, Inc. $22.62 11/21/2025 Food and Beverage Undisputed 06/30/2026 1234498670 CMS
ViiV Healthcare Company $22.56 02/11/2025 Food and Beverage Undisputed 06/30/2026 1189523996 CMS
ViiV Healthcare Company $22.26 04/02/2025 Food and Beverage Undisputed 06/30/2026 1189588395 CMS
ViiV Healthcare Company $27.77 04/28/2025 Food and Beverage Undisputed 06/30/2026 1189569253 CMS
ViiV Healthcare Company $18.56 05/14/2025 Food and Beverage Undisputed 06/30/2026 1189553666 CMS
ViiV Healthcare Company $25.79 05/30/2025 Food and Beverage Undisputed 06/30/2026 1189599670 CMS
ViiV Healthcare Company $18.85 06/25/2025 Food and Beverage Undisputed 06/30/2026 1189526824 CMS
ViiV Healthcare Company $20.26 07/24/2025 Food and Beverage Undisputed 06/30/2026 1189589979 CMS
ViiV Healthcare Company $18.26 09/16/2025 Food and Beverage Undisputed 06/30/2026 1189609161 CMS
ViiV Healthcare Company $26.26 09/30/2025 Food and Beverage Undisputed 06/30/2026 1189585497 CMS
ViiV Healthcare Company $17.83 10/14/2025 Food and Beverage Undisputed 06/30/2026 1189510458 CMS
ViiV Healthcare Company $33.64 11/05/2025 Food and Beverage Undisputed 06/30/2026 1189605363 CMS
ViiV Healthcare Company $22.66 11/23/2025 Food and Beverage Undisputed 06/30/2026 1189602825 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2024, 2025
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.